This Article Full Text Full Text (PDF) All Versions of this Article: 18/1/252    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kovacic, A. Articles by Clyne, C. D. Search for Related Content PubMed PubMed Citation Articles by Kovacic, A. Articles by Clyne, C. D.

Inhibition of Aromatase Transcription Via Promoter II by Short Heterodimer Partner in Human Preadipocytes

Prince Henry’s Institute of Medical Research (A.K., C.J.S., E.R.S., C.D.C.), Clayton, Victoria 3168, Australia; and Department of Biochemistry and Molecular Biology (A.K., E.R.S., C.D.C.), Monash University, Clayton Campus, Victoria 3800, Australia

Address all correspondence and requests for reprints to: Agnes Kovacic, P.O. Box 5152, Clayton, Victoria 3168, Australia. E-mail: agnes.kovacic{at}phimr.monash.edu.au.

Estrogen synthesis from C₁₉ precursors is catalyzed by aromatase cytochrome P450. Overexpression of aromatase through atypical promoter usage (use of promoter II) in adipose tissue contributes to breast cancer development and progression. One tumor-derived factor that appears to contribute to this process is prostaglandin E₂ (PGE₂). A factor that regulates aromatase expression downstream of PGE₂ is liver receptor homolog-1 (LRH-1). In a study of factors that inhibit LRH-1, we have examined the ability of short heterodimer partner (SHP) to inhibit aromatase transcription mediated by LRH-1 in preadipocytes. RT-PCR analysis indicated that both LRH-1 and SHP are expressed in human preadipocytes. To assess the effect of SHP on aromatase transcription, a transient transfection system was established using 3T3-L1 preadipocytes. Expression of SHP completely inhibited activity of an aromatase promoter II reporter gene induced by LRH-1. The combined treatment of forskolin and phorbol ester (which mimic PGE₂) as well as LRH-1, which maximally induced reporter gene expression (140-fold), was also completely inhibited by SHP. This effect of SHP was mediated by inhibition of LRH-1 transcriptional activity, as measured by activity of GAL4-LRH-1 fusion constructs, and by inhibition of LRH-1 binding to promoter II. We conclude that SHP is a potent inhibitor of aromatase transcription in preadipocytes. Modulation of SHP expression and/or activity in adipose tissue may therefore have significant effects on aromatase expression and estrogen production in breast adipose tissue.

NURSA Molecule Pages Link:

Nuclear Receptors:   SHP  |  LRH-1

This article has been cited by other articles:

				L. Farhana, M. I. Dawson, M. Leid, L. Wang, D. D. Moore, G. Liu, Z. Xia, and J. A. Fontana Adamantyl-Substituted Retinoid-Related Molecules Bind Small Heterodimer Partner and Modulate the Sin3A Repressor Cancer Res., January 1, 2007; 67(1): 318 - 325. [Abstract] [Full Text] [PDF]

				K. E. Swales, M. Korbonits, R. Carpenter, D. T. Walsh, T. D. Warner, and D. Bishop-Bailey The farnesoid x receptor is expressed in breast cancer and regulates apoptosis and aromatase expression. Cancer Res., October 15, 2006; 66(20): 10120 - 10126. [Abstract] [Full Text] [PDF]

				I. Kijima, S. Phung, G. Hur, S.-L. Kwok, and S. Chen Grape Seed Extract Is an Aromatase Inhibitor and a Suppressor of Aromatase Expression Cancer Res., June 1, 2006; 66(11): 5960 - 5967. [Abstract] [Full Text] [PDF]

				R. Safi, A. Kovacic, S. Gaillard, Y. Murata, E. R. Simpson, D. P. McDonnell, and C. D. Clyne Coactivation of Liver Receptor Homologue-1 by Peroxisome Proliferator-Activated Receptor {gamma} Coactivator-1{alpha} on Aromatase Promoter II and Its Inhibition by Activated Retinoid X Receptor Suggest a Novel Target for Breast-Specific Antiestrogen Therapy Cancer Res., December 15, 2005; 65(24): 11762 - 11770. [Abstract] [Full Text] [PDF]

				S. E. Bulun, Z. Lin, G. Imir, S. Amin, M. Demura, B. Yilmaz, R. Martin, H. Utsunomiya, S. Thung, B. Gurates, et al. Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to Treatment Pharmacol. Rev., September 1, 2005; 57(3): 359 - 383. [Abstract] [Full Text] [PDF]

				R. Kumar, A. E. Gururaj, R. K. Vadlamudi, and S. K. Rayala The Clinical Relevance of Steroid Hormone Receptor Corepressors Clin. Cancer Res., April 15, 2005; 11(8): 2822 - 2831. [Abstract] [Full Text] [PDF]